Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Overview of attention for article published in PharmacoEconomics, November 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy: 1 policy source
twitter: 3 X users

facebook: 1 Facebook page

Readers on

mendeley: 46 Mendeley

Summary Policy documents X Facebook

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,975 followers.

RT @ManuelaJoore: Decision making under uncertainty and how HTA helps: Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evid…

12 Feb 2019

Reply Repost Favourite

Decision making under uncertainty and how HTA helps: Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal https://t.co/4M3I4DIPaF

07 Feb 2019

Reply Repost Favourite

#HealthEconJA Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal https://t.co/XEUWNTrBNK

14 Nov 2018

Reply Repost Favourite